Skip to content
  • LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn
  • Landscape

Ricky Solorzano

  • Vivodyne CEO Discusses FDA’s Move Away from Animal Testing and the Future of Humanized Drug Development
    April 27, 2025

    Vivodyne CEO Discusses FDA’s Move Away from Animal Testing and the Future of Humanized Drug Development

    Ricky Solorzano
  • Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology
    April 27, 2025

    Organovo Rebrands as VivoSim Labs to Advance 3D Bioprinting Technology

    Ricky Solorzano
  • Cellbricks Reports Preclinical Success with Bioprinted Tissue in Mice
    April 16, 2025

    Cellbricks Reports Preclinical Success with Bioprinted Tissue in Mice

    Ricky Solorzano
  • FluidForm Bio Launches $1.24M Crowdfunding Round to Advance Bioprinted Diabetes Therapy
    April 16, 2025

    FluidForm Bio Launches $1.24M Crowdfunding Round to Advance Bioprinted Diabetes Therapy

    Ricky Solorzano
  • Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs
    April 8, 2025

    Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs

    Ricky Solorzano
  • Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies
    April 3, 2025

    Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

    Ricky Solorzano
  • LyGenesis Receives Green Light to Advance Organ Regeneration Trial
    April 3, 2025

    LyGenesis Receives Green Light to Advance Organ Regeneration Trial

    Ricky Solorzano
  • How Cellino and Matricelf are Advancing Neural Tissue Engineering
    March 18, 2025

    How Cellino and Matricelf are Advancing Neural Tissue Engineering

    Ricky Solorzano
  • CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program
    March 18, 2025

    CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program

    Ricky Solorzano
  • Vericel – Poised for Growth with Expanding Indications and Strong Margins
    March 18, 2025

    Vericel – Poised for Growth with Expanding Indications and Strong Margins

    Ricky Solorzano
Previous Page
1 … 7 8 9 10 11 … 16
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    The Business of Biofabrication

    Have a WordPress.com account? Log in now.

  • The Business of Biofabrication
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar